Skip to main content

Becton Dickinson & Co

BDX
Exchange
NYSE
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0000010795

In the last 90 days, Becton Dickinson & Co insiders filed 0 open-market purchases and 4 sales; 1,446 institutions reported holding it in 13F filings for Q2 2026, worth $43.3B in total; superinvestors Greenhaven Associates and Harris Associates (Oakmark) hold it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Becton Dickinson & Co insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
4 filings
3 insiders, $1.25M in total
Insiders trading
3
Net value
−$1.25M
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Becton Dickinson & Co, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Becton Dickinson & Co
NameTitleLast reported holdingLast filingFilings, past year
Roque VitorEVP & Chief Financial Officer8,041Sep 3, 20263
Feld MichaelEVP, Chief Revenue Officer19,720Aug 27, 202614
Polen Thomas E JrChairman, CEO and President110,163Aug 14, 20263
Goette RolandEVP and President, EMEA14,856Aug 12, 20262
Huffines Robert LutherDirector1,279Aug 6, 20265
Byington Carrie LDirector5,018Aug 6, 20265
Muhsin BilalEVP & President Connected Care41,359Jul 6, 20262
Garrison Michael DavidEVP & Pres Med.Essntl&BioPharm13,172Jun 25, 20265
Menziuso PeterEVP and President, BDI14,258Jun 2, 20261
Neal Shana CarolEVP and Chief People Officer23,966Apr 6, 20262
Minnix LaneshaEVP and General Counsel7,492Mar 17, 20261
Spikner Pamela L.SVP Controller & CAO3,323Mar 4, 20263
Scott Bertram LDirector36,763Feb 18, 20263
Jones Christopher Ian MontagueDirector24,304Feb 5, 20263
Ring Timothy MDirector59,160Jan 29, 20261
Eckert R AndrewDirector10,423Jan 29, 20261
Hayes GregoryDirector7,159Jan 29, 20261
Henderson Jeffrey WilliamDirector9,143Jan 29, 20261
Brown William MDirector4,663Jan 29, 20261
Wright JacquelineDirector1,279Jan 29, 20262
Waldstreicher JoanneDirector3,391Jan 29, 20261
Shan DavidEVP and Chief ISC Officer8,926Jan 6, 20262
DelOrefice ChristopherEVP & Chief Financial Officer22,982Dec 1, 20251
Mocherla Pavan KumarEVP & President, Greater Asia5,763Dec 1, 20251
Byrd RichardEVP & President Interventional13,849Dec 1, 20251
Fraser ClaireDirector22,226Sep 11, 20250
Burzik Catherine MDirector14,264Jan 30, 20250
Quinn MichelleEVP and General Counsel4,955Dec 3, 20240
Ezell Antoine CEVP, President Americas & CMO11,970Nov 29, 20240
Spoerel Thomas JSVPController & Chief Acct Off1,928Jul 2, 20240
Hickey DavidEVP & President, Life Sciences5,862Nov 28, 20230
Larsen Marshall ODirector28,919Jan 26, 20230
Khichi Samrat S.EVP and General Counsel9,251Jan 5, 20230
Grover RishiEVP and Chief ISC Officer9,439Jul 12, 20220
Lim James CExecutive Vice President23,941Jun 24, 20220
Larson Betty DEVP HR & CHRO5,872Feb 28, 20220
Campion Simon DEVP and Segment President10,319Feb 14, 20220
Conroy AlexandreEVP of Integrated Supply Chain21,260Feb 7, 20220
Melcher David FDirector6,180Jan 27, 20220
Pomeroy ClaireDirector9,982Jan 26, 20220
Reidy Christopher RCFO and EVP of Administration31,524Nov 30, 20210
Mas Ribo AlbertoEVP and Pres, Life Sciences11,662Nov 30, 20210
Rimel Rebecca WDirector10,618Sep 8, 20210

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Aug 27, 2026 (view filing)4:28 PM ETAug 261 dayFeld MichaelEVP, Chief Revenue OfficerSSale−165$188.49−$31.1K−0.8%19.7K after10b5-1
Aug 14, 2026 (view filing)4:36 PM ETAug 131 dayPolen Thomas E JrChairman, CEO and PresidentSSale−4.15K$185.00−$768.1K−3.6%110.2K after10b5-1
Aug 12, 2026 (view filing)5:27 PM ETAug 111 dayGoette RolandEVP and President, EMEASSale−2.44K$180.84−$440.9K−14.1%14.9K after
Jul 28, 2026 (view filing)11:16 AM ETJul 271 dayFeld MichaelEVP, Chief Revenue OfficerSSale−75$157.13−$11.8K−0.4%20.9K after10b5-1
Jun 26, 2026 (view filing)Jun 26Same dayFeld MichaelEVP, Chief Revenue OfficerSSale−75$152.80−$11.5K−0.4%21.0K after10b5-1
Jun 25, 2026 (view filing)Jun 241 dayGarrison Michael DavidEVP & Pres Med.Essntl&BioPharmSSale−1.10K$145.66−$160.2K−7.7%13.2K after10b5-1
Jun 11, 2026 (view filing)Jun 101 dayGarrison Michael DavidEVP & Pres Med.Essntl&BioPharmSSale−1.10K$151.48−$166.6K−7.2%14.3K after10b5-1
Jun 3, 2026 (view filing)Jun 12 daysPolen Thomas E JrChairman, CEO and PresidentSSale−2.76K$146.35−$404.5K−2.4%110.2K after10b5-1
May 27, 2026 (view filing)May 261 dayFeld MichaelEVP, Chief Revenue OfficerSSale−75$147.35−$11.1K−0.4%21.1K after10b5-1
Apr 28, 2026 (view filing)Apr 271 dayFeld MichaelEVP, Chief Revenue OfficerSSale−74$151.94−$11.2K−0.3%21.2K after10b5-1
Mar 27, 2026 (view filing)Mar 261 dayFeld MichaelEVP, Chief Revenue OfficerSSale−75$156.83−$11.8K−0.4%21.2K after10b5-1
Feb 27, 2026 (view filing)Feb 261 dayFeld MichaelEVP, Chief Revenue OfficerSSale−75$181.84−$13.6K−0.4%21.3K after10b5-1
Feb 18, 2026 (view filing)Feb 18Same dayScott Bertram LDirectorSSale−953$182.61−$174.0K−2.5%36.8K after
Jan 28, 2026 (view filing)Jan 262 daysFeld MichaelEVP, CRO & Pres. Life SciencesSSale−75$202.73−$15.2K−0.5%16.4K after10b5-1
Jan 16, 2026 (view filing)Jan 151 dayGarrison Michael DavidEVP & Pres Med.Essntl&BioPharmSSale−1.61K$207.46−$334.0K−11.7%12.1K after2 lots10b5-1
Dec 29, 2025 (view filing)Dec 263 daysFeld MichaelEVP, CRO & Pres. Life SciencesSSale−74$196.08−$14.5K−0.4%16.5K after10b5-1
Dec 17, 2025 (view filing)Dec 17Same dayGarrison Michael DavidEVP & Pres Med.Essntl&BioPharmSSale−629$196.03−$123.3K−4.6%13.1K after10b5-1
Dec 2, 2025 (view filing)Dec 11 dayFeld MichaelEVP, CRO & Pres. Life SciencesSSale−75$193.36−$14.5K−0.5%16.6K after10b5-1
Nov 7, 2025 (view filing)Nov 7Same dayScott Bertram LDirectorSSale−217$176.58−$38.3K−0.6%35.8K after
Oct 28, 2025 (view filing)Oct 271 dayFeld MichaelEVP & President, Life SciencesSSale−57$186.01−$10.6K−0.7%8.24K after10b5-1
Sep 29, 2025 (view filing)Sep 263 daysFeld MichaelEVP & President, Life SciencesSSale−58$181.03−$10.5K−0.7%8.30K after10b5-1
Sep 11, 2025 (view filing)Sep 101 dayFraser ClaireDirectorSSale−917$187.50−$171.9K−4.0%22.2K after
Aug 26, 2025 (view filing)Aug 224 daysFeld MichaelEVP & President, Life SciencesSSale−57$197.99−$11.3K−0.7%8.36K after10b5-1
Aug 11, 2025 (view filing)Aug 11Same dayHayes GregoryDirectorPPurchase+5.25K$191.57+$1.01M+659.5%6.05K after
Aug 8, 2025 (view filing)Aug 8Same dayFraser ClaireDirectorSSale−863$192.30−$166.0K−3.6%23.1K after
Jul 22, 2025 (view filing)Jul 184 daysGarrison Michael DavidEVP & President, MedicalSSale−1.19K$180.29−$213.6K−19.5%4.89K after2 lots10b5-1
Jun 2, 2025 (view filing)Jun 2Same dayShan DavidEVP and Chief ISC OfficerSSale−1.17K$171.19−$199.6K−20.3%4.58K after10b5-1
Apr 10, 2025 (view filing)Apr 91 dayGarrison Michael DavidEVP & President, MedicalSSale−479$197.28−$94.5K−8.9%4.89K after10b5-1
Mar 19, 2025 (view filing)Mar 181 dayByrd RichardEVP & President InterventionalSSale−459$230.00−$105.6K−6.2%6.95K after10b5-1
Mar 13, 2025 (view filing)Mar 121 dayByrd RichardEVP & President InterventionalSSale−1.94K$224.91−$436.3K−20.7%7.41K after10b5-1
Feb 12, 2025 (view filing)Feb 12Same dayScott Bertram LDirectorSSale−700$227.99−$159.6K−1.9%36.0K after
Feb 10, 2025 (view filing)Feb 10Same dayHenderson Jeffrey WilliamDirectorPPurchase+1.50K$233.62+$350.4K+23.0%8.02K after
Jan 22, 2025 (view filing)Jan 211 dayShan DavidEVP and Chief ISC OfficerSSale−500$240.00−$120.0K−8.0%5.74K after10b5-1
Jan 22, 2025 (view filing)Jan 211 dayNeal Shana CarolEVP and Chief People OfficerSSale−787$240.00−$188.9K−4.9%15.4K after10b5-1
Jan 21, 2025 (view filing)Jan 174 daysGarrison Michael DavidEVP & President, MedicalSSale−597$236.51−$141.2K−9.7%5.54K after10b5-1
Jan 10, 2025 (view filing)Jan 73 daysNeal Shana CarolEVP and Chief People OfficerSSale−788$235.00−$185.2K−4.6%16.2K after10b5-1
Dec 20, 2024 (view filing)Dec 191 dayGarrison Michael DavidEVP & President, MedicalSSale−2.84K$223.33−$633.8K−31.6%6.14K after10b5-1
Dec 10, 2024 (view filing)Dec 6-94 daysGoette RolandEVP and President, EMEASSale−5.12K$220.76−$1.13M−26.5%14.2K after2 lots10b5-1
Dec 10, 2024 (view filing)Dec 64 daysNeal Shana CarolEVP and Chief People OfficerSSale−1.00K$220.49−$220.5K−5.6%17.0K after10b5-1
Dec 6, 2024 (view filing)Dec 51 dayShan DavidEVP and Chief ISC OfficerSSale−1.50K$220.25−$330.4K−19.3%6.29K after10b5-1
Jun 11, 2024 (view filing)Jun 101 daySpoerel Thomas JSVP,Controller&Chief Acct OffSSale−300$239.31−$71.8K−13.2%1.98K after10b5-1
May 16, 2024 (view filing)May 151 dayGoette RolandEVP and President EMEASSale−3.30K$236.73−$781.2K−22.6%11.3K after3 lots10b5-1
May 15, 2024 (view filing)May 132 daysGoette RolandEVP and President EMEASSale−3.30K$236.70−$781.1K−18.4%14.6K after3 lots10b5-1
May 1, 2024 (view filing)Apr 301 dayGarrison Michael DavidEVP & President MedicalSSale−1.72K$232.81−$399.3K−24.2%5.38K after10b5-1
Mar 15, 2024 (view filing)Mar 141 daySpoerel Thomas JSVP,Controller&Chief Acct OffSSale−282$238.29−$67.2K−11.0%2.28K after10b5-1
Dec 12, 2023 (view filing)Dec 111 dayGarrison Michael DavidEVP & President MedicalSSale−1.24K$232.46−$288.0K−14.6%7.27K after10b5-1
Nov 29, 2023 (view filing)Nov 281 dayByrd RichardEVP & President InterventionalSSale−2.16K$238.47−$514.1K−34.4%4.12K after10b5-1
Sep 6, 2023 (view filing)Sep 51 dayByrd RichardEVP & President InterventionalSSale−459$274.48−$126.0K−11.8%3.44K after10b5-1
Aug 30, 2023 (view filing)Aug 282 daysFraser ClaireDirectorSSale−848$281.66−$238.8K−3.8%21.6K after
Aug 14, 2023 (view filing)Aug 113 daysHickey DavidEVP & President, Life SciencesSSale−2.97K$277.85−$826.3K−41.5%4.20K after10b5-1